It is a healthcare private limited company based in Haridwar, Uttarakhand, India, established in 2015.
2015 | Haridwar, Uttarakhand, India | ActiveCyancare Therapeutics India Private Limited, a active private limited company, was established on 16 March 2015 in Haridwar, Uttarakhand, India. Engaging in other hospital and medical care activities within the healthcare sector, it holds CIN: U24297UR2015PTC001444. Registered under ROC Roc Uttarakhand. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Rakesh Kumar Barnwal (Director), Swadesh Barnwal (Director), Satyendra Kumar Rai (Director). Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Vill-Rampur Roorkee Post-Rampur Roorkee, Haridwar, Uttarakhand, 247667.
U24297UR2015PTC001444
001444
16 March 2015
₹1.00 M
₹0.10 M
Roc Uttarakhand
Unlisted
Active
Explore comprehensive insights into Cyancare Therapeutics India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rakesh Kumar Barnwal | Director | 16 Mar 2015 | Current |
| Swadesh Barnwal | Director | 16 Mar 2015 | Current |
| Satyendra Kumar Rai | Director | 10 Apr 2015 | Current |
| Durgeshwar Tiwari | Director | 10 Apr 2015 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cyancare Therapeutics India Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 32.57% decrease. The company also saw a substantial fall in profitability, with a 18.41% decrease in profit. The company's net worth Soared by an impressive increase of 46.29%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Cyancare Therapeutics India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Cyancare Therapeutics India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Cyancare Therapeutics India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cyancare Therapeutics India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Cyancare Therapeutics India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Cyancare Therapeutics India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Uttarakhand. was documented.
Satyendra Kumar Rai was appointed as a Director was appointed as a Director on 10 Apr 2015 & has been associated with this company since 10 years 7 months . was recorded as a recent event.
Durgeshwar Tiwari was appointed as a Director was appointed as a Director on 10 Apr 2015 & has been associated with this company since 10 years 7 months . was recorded as a recent event.
Progress on Rakesh Kumar Barnwal was appointed as a Director was appointed as a Director on 16 Mar 2015 & has been associated with this company since 10 years 8 months . was documented.
The activity Swadesh Barnwal was appointed as a Director was appointed as a Director on 16 Mar 2015 & has been associated with this company since 10 years 8 months . was completed.
The CIN of Cyancare Therapeutics India Private Limited is U24297UR2015PTC001444.
Cyancare Therapeutics India Private Limited is headquartered at Vill-Rampur Roorkee Post-Rampur Roorkee, Haridwar, Uttarakhand, 247667.
Cyancare Therapeutics India Private Limited was incorporated on 16 March 2015.
The current directors of Cyancare Therapeutics India Private Limited are
The primary industry of Cyancare Therapeutics India Private Limited is Healthcare.
Cyancare Therapeutics India Private Limited is unlisted.
The authorized capital of Cyancare Therapeutics India Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
The compliance status of Cyancare Therapeutics India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX